C Weiler
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Neutropenia and Cancer Infections
- Cancer Treatment and Pharmacology
Papers in
- Oncology 3
- Cancer Treatment and Pharmacology 2
-
- Acute Lymphoblastic Leukemia research 3
- Co-authors
- John H. Glick (3 shared papers)Donna Glover (2 shared papers)Kevin R. Fox (1 shared paper)DuPont Guerry (1 shared paper)Morton M. Kligerman (1 shared paper)C B Begg (1 shared paper)Marek J. Bozdech (1 shared paper)J M Bennett (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Tumor Biology (1 paper)Blood (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)PubMed (3 papers)
- Partner nations
- United StatesGermany
In The Last Decade
C Weiler
8 papers receiving 407 citations
Peers
Comparison fields: 5 of 62
- Hematology 150
- Oncology 162
- Radiology, Nuclear Medicine and Imaging 79
- Genetics 32
- Radiation 23
Countries citing papers authored by C Weiler
This map shows the geographic impact of C Weiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Weiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Weiler more than expected).
Fields of papers citing papers by C Weiler
This network shows the impact of papers produced by C Weiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Weiler. The network helps show where C Weiler may publish in the future.
Co-authors
The 20 scholars most cited alongside C Weiler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 151 | |
| 2 | 1984 | 118 | |
| 3 | 1986 | 100 | |
| 4 | Final report of the phase I trial of single-dose WR-2721 [S-2-(3-aminopropylamino)ethylphosphorothioic acid]. | 1986 | 37 |
| 5 | Integration of full-dose adjuvant chemotherapy with definitive radiotherapy for primary breast cancer: four-year update. | 1988 | 8 |
| 6 | 1996 | 7 | |
| 7 | Induction therapy and intensive consolidation with daunorubicin, cytosine arabinoside, and 6-thioguanine in adult acute nonlymphoblastic leukemia. | 1981 | 4 |
| 8 | 1979 | 1 |
About C Weiler
C Weiler is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Hematology, Genetics and Cancer Research, having authored 8 papers that have together received 426 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Cancer Treatment and Pharmacology (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Amino Acid Enzymes and Metabolism (1 paper), Metabolism and Genetic Disorders (1 paper), Cancer therapeutics and mechanisms (1 paper) and Hematopoietic Stem Cell Transplantation (1 paper). The work is most often cited by research in Hematology (150 citations), Oncology (162 citations), Radiology, Nuclear Medicine and Imaging (79 citations), Genetics (32 citations) and Radiation (23 citations). C Weiler has collaborated with scholars based in United States and Germany. Frequent co-authors include John H. Glick, Donna Glover, Kevin R. Fox, DuPont Guerry, Morton M. Kligerman, C B Begg, Marek J. Bozdech, J M Bennett, PA Cassileth and Selwyn J. Hurwitz. Their work appears in journals such as Journal of Clinical Oncology, Tumor Biology, Blood, International Journal of Radiation Oncology*Biology*Physics and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.